BOCCARELLI, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 3.550
EU - Europa 843
AS - Asia 634
SA - Sud America 12
OC - Oceania 4
Totale 5.043
Nazione #
US - Stati Uniti d'America 3.544
CN - Cina 438
SE - Svezia 282
SG - Singapore 160
IT - Italia 159
UA - Ucraina 110
DE - Germania 98
FI - Finlandia 87
GB - Regno Unito 40
IN - India 19
BE - Belgio 15
FR - Francia 14
IE - Irlanda 13
RU - Federazione Russa 12
BR - Brasile 8
CA - Canada 6
CZ - Repubblica Ceca 5
IR - Iran 5
AU - Australia 4
VN - Vietnam 4
BD - Bangladesh 2
KR - Corea 2
LT - Lituania 2
AR - Argentina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
HK - Hong Kong 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
TR - Turchia 1
VE - Venezuela 1
Totale 5.043
Città #
Fairfield 400
Woodbridge 374
Chandler 370
Jacksonville 262
Ashburn 246
Nyköping 242
Houston 209
Seattle 190
Cambridge 171
Ann Arbor 164
Wilmington 156
Singapore 111
Bari 101
Nanjing 101
Lawrence 88
Roxbury 88
Beijing 80
New York 78
Des Moines 60
Boardman 56
Princeton 38
Helsinki 31
Inglewood 31
Hebei 26
Dearborn 25
Nanchang 25
Shenyang 24
San Diego 22
Jiaxing 19
Brooklyn 18
Santa Clara 17
Pune 16
Brussels 15
Tianjin 15
Los Angeles 13
Dublin 12
Guangzhou 10
Milan 9
Shanghai 8
Changsha 7
Kunming 7
Ningbo 7
Paris 7
San Francisco 6
Washington 6
Wuxi 6
Ardabil 5
Brno 5
Hefei 5
Dong Ket 4
Jinan 4
Leawood 4
London 4
Redwood City 4
Taizhou 4
Toronto 4
Wuhan 4
Auburn Hills 3
Lanzhou 3
Marseille 3
Munich 3
San Mateo 3
Terlizzi 3
Yiwu 3
Zhengzhou 3
Augusta 2
Baotou 2
Berlin 2
Dongyang 2
Edinburgh 2
Grafing 2
Jinhua 2
Kilburn 2
Melbourne 2
Monmouth Junction 2
Mumbai 2
Nantong 2
Bandar Seri Begawan 1
Baoding 1
Brescia 1
Brisbane 1
Caracas 1
Chicago 1
Chiswick 1
Criciúma 1
Dalian 1
Dhaka 1
Falls Church 1
Frankfurt am Main 1
Fuzhou 1
Hangzhou 1
Harbin 1
Heze 1
Hong Kong 1
Hounslow 1
Iguatu 1
Indiana 1
Kaifeng 1
Kostyantynivka 1
La Canada Flintridge 1
Totale 4.085
Nome #
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 156
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 141
A new class of 1-aryl-5,6-dihydropyrrolo[2,1-a]isoquinoline derivatives as reversers of P-glycoprotein-mediated multidrug resistance in tumor cells 132
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 127
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 120
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 115
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 108
null 104
Novel Antiproliferative Biphenyl Nicotinamide: NMR Metabolomic Study of its Effect on the MCF-7 Cell in Comparison with Cisplatin and Vinblastine 104
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 101
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 95
null 90
null 88
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 85
Endothelial cells in the bone marrow of patients with multiple myeloma 82
Platinum(II) based anticancer agents with a trans geometry 81
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 81
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 75
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 74
Antitumour platinum-iminoether complexes 73
Antitumour platinum iminoether complexes 71
null 68
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 68
null 67
null 66
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 66
null 65
null 65
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 64
Antitumour platinum iminoether complexes 64
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 63
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 62
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 60
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 60
Antitumour ruthenium(II)-dimethylsulfoxide complexes 60
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 59
Bone Marrow Fibroblasts and Multiple Myeloma Progression 56
Antitumor activity of trans platinum complexes 56
Inhibition of matrix metallo proteinases activity by platinum complexes 55
null 55
null 55
null 53
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 52
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 52
An NMF-Based Methodology for Selecting Biomarkers in the Landscape of Genes of Heterogeneous Cancer-Associated Fibroblast Populations 52
null 52
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 51
null 51
Cytotoxicity of some platinum(IV) complexes with ethylenediamine-N,N'-di-3-prppionato ligands 50
Reductive Domino Reaction to Access Chromeno [2, 3-c] isoquinoline-5-amines with Antiproliferative Activities Against Human Tumor Cells 50
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 48
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 48
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 48
Genomic analysis of the differential processing of antitumor-active and antitumor-inactive trans platinum compuonds 46
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 45
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 45
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 45
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 44
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 43
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 42
Synthesis and in vitro antitumour activity of platinum acetonimine complexes 40
Complessi antitumorali di platino a geometria trans 40
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 39
Inhibition of matrix metallo proteinase activity by novel platinum complexes with bisphosphonate analogues 38
Platinum complexes with cyclic ligands mimicking iminoether species, synthesis and biological activity 37
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 35
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 34
null 33
null 33
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 33
In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands 32
Pharmacological actions of new platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 31
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 31
Analysis of fibroblast genes selected by NMF to reveal the potential crosstalk between ulcerative colitis and colorectal cancer 31
Colorectal cancer in Crohn's disease evaluated with genes belonging to fibroblasts of the intestinal mucosa selected by NMF 31
A new generation of platinum anticancer complexes with trans geometry 29
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 29
Synthesis and in vitro and in vivo antitumour activity of new platinum-iminoether derivatives with different configuration at the iminoether ligands 29
The activation of trans geometry in antitumor platinum complexes from iminoether to acetonimine ligands 28
Platinum (II) complexes containing iminoethers: a trans platinum antitumour agent 28
null 28
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 25
Screening tests for selecting anticancer metal compounds 25
Interazione DNA-isomeri del [PtCl2(DACH)] 24
DNA interaction properties of platinum –iminoether complexes 22
Rhodium (III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH] [trans-RhCl4(Im)2] (Im = imidazole) 22
New platinum antitumor complexes with chiral diamines 21
Platinum(II) complexes with acyclovir: synthesis and biological activity 20
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 20
A trans-platinum complex showing higher antitumor activity than the cis congeners 20
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: synthesis, in vitro antitumour activity, and DNA interaction properties 20
Differential processing of antitumour-active and antitumour-inactive trans platinum compounds by SKOV-3 ovarian cancer cells 20
Complessi antitumorali di platino a geometria trans 19
Platinum Complexes Can Inhibit Matrix Metalloproteinase Activity: Platinum-Diethyl[(methylsulfinyl)methyl]phosphonate Complexes as Inhibitors of Matrix Metalloproteinases 2, 3, 9, and 12 18
Dna interaction properties of new platinum-iminoether derivatives with different configuration at the iminoether ligands 17
In vitro antitumor activity of 2-acetyl pyridine 4n-ethyl thiosemicarbazone and its platinum(II) and palladium(II) complexes 17
Complessi antimetastatici di rutenio 16
Cluster of resistance-inducing genes in MCF-7 cells by estrogen, insulin, methotrexate and tamoxifen extracted via NMF 15
Nami-A: A ruthenium compound active on solid tumour metasteses by altering the interaction between tumour cells and host 15
Synthesis, Biophysical Studies, and Antiproliferative Activity of Platinum(II) Complexes Having 1,2-Bis(aminomethyl)carbobicyclic Ligands 15
Totale 5.314
Categoria #
all - tutte 23.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020614 0 0 0 0 0 63 112 74 105 70 174 16
2020/2021957 111 80 108 36 123 67 47 51 118 109 74 33
2021/2022555 15 90 4 9 25 23 30 19 28 34 102 176
2022/2023995 149 106 78 75 130 118 8 144 147 9 15 16
2023/2024430 30 50 19 18 60 135 4 33 11 10 2 58
2024/2025365 89 26 129 52 59 10 0 0 0 0 0 0
Totale 5.411